Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of AAVB-039 in patients with Stargardt disease
BelgiumA study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors
France
PolandA study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status
FranceA study to compare the effectiveness and safety of subcutaneous frexalimab versus intravenous frexalimab in adults with multiple sclerosis
BelgiumA study to evaluate the use of leflutrozole to improve semen quality in men with non-obstructive azoospermia
DenmarkA study to evaluate the effectiveness of bleomycin sulfate for treating patients with low-flow vascular malformations using electrosclerotherapy.
SloveniaA study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes
CzechiaA study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer
FranceA study to evaluate the safety and tolerability of tinlarebant in patients with Stargardt disease
BelgiumA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
BelgiumA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
